AstraZeneca PLC reports share transaction
- 10/06/2026 - Acquired 2 shares
- Price: $159.8
- Reporting person: Sharma Mani
Mani Sharma, reporting
AZNCF
ASTRAZENECA PLC SEC filings
Every EDGAR filing for ASTRAZENECA PLC (AZNCF), newest first, with AI summaries and stories.
- Ticker
- AZNCF
- CIK
- 901832
- Latest filing
- Oct 8
Insider activity
No open-market insider buys in the last 30 days.
Also: 1 grant or exercise.
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE4ASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE AstraZeneca completes $2B investment in Summit
- $2 billion equity investment in Summit Therapeutics
- Accelerates development of ivonescimab, a first-in-class antibody
- Collaboration with Daiichi Sankyo to evaluate Datroway with ivonescimab
ROUTINE6-KASTRAZENECA PLCAZNCFLIVE AstraZeneca PLC announces collaboration
- Collaboration with Summit Therapeutics to evaluate Datroway with ivonescimab.
- Phase III trial in first-line triple-negative breast cancer planned.
ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE4ASTRAZENECA PLCAZNCFLIVE Mani Sharma, insider filing for AZNCF
Mani Sharma, reporting
ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE4ASTRAZENECA PLCAZNCFLIVE Mani Sharma, insider filing for AZNCF
Mani Sharma, reporting
ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE4ASTRAZENECA PLCAZNCFLIVE Mani Sharma, insider filing for AZNCF
Mani Sharma, reporting
ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE11-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE4ASTRAZENECA PLCAZNCFLIVE Mani Sharma, insider filing for AZNCF
Mani Sharma, reporting
ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE ROUTINE6-KASTRAZENECA PLCAZNCFLIVE